Efficacy of adalimumab therapy in experimental rat sclerosing encapsulated peritonitis model.

CONCLUSION: Adalimumab can prevent SEP development. PMID: 31686457 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31686457?dopt=Abstract

Source: Croatian Medical Journal - October 30, 2019 Category: General Medicine Authors: Akgun Y, Bakirdogen S, Kadioglu Kocak MG, Bektas S, Demir C, Akbal E, Elmas S Tags: Croat Med J Source Type: research